Global RNA Probe Market

RNA Probe Comprehensive Study by Type (Plus-Sense RNA Probes, Minus-Sense RNA Probes, Antisense RNA Probes), Application (In Northern blotting, RNase protection assays, In situ hybridization, Southern blotting), Labels (Radioisotope, - 32P, -125I, Chemical, - Biotin, Others), End User (Clinical Research Institutes, Hospital & Diagnostic Laboratories, Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others) Players and Region - Global Market Outlook to 2027

RNA Probe Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global RNA Probe Market Overview:
RNA probes are stretches of single-stranded RNA that identify the presence of complementary nucleic acid sequences (also known as target sequences) through hybridization. In order to be detected, RNA probes are typically labeled, for instance with radioisotopes, epitopes, biotin, or fluorophores. North America is estimated to have most significant share in the market. The factors attributed to the growth are the high incidence rate of genetic disorders leading to congenital disabilities, developmental disabilities, and other metabolic syndromes.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


RNA Probe Market Dynamics:
AttributesDetails
Growth Drivers
  • Growing Incidence of Cancer and Hereditary Diseases
  • Need To Develop RNA-Based Biomarkers and Measure RNA Expression Has Increased
Restraints
  • Exploitation of RNA Products as Weapons
  • Stringent FDA Regulations for Laboratory Methods
Road Blocks / Challenges
  • Lack of Skilled Professionals
  • Emerging Infections and Rapidly Evolving Pathogens
  • Very Sensitive To Degradation by RNase
Gaps & Opportunities
  • Untapped Markets in Emerging Nations


Competitive Landscape:
Global RNA probe is a fragmented market due to the presence of various players. The players are focusing more on research and development. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Some of the key players profiled in the report are Sigma-Aldrich Co. LLC. (Argentina), Signet Laboratories, Inc. (United States), Kamiya Biomedical Co (United States), Sigma-Genosys (United States), Clontech Laboratories, Inc. (United States), Promega Corporation (United States), New England Biolabs (United States), Kaneka Eurogentec S.A. (Belgium), Advanced Cell Diagnostics, Inc. (United States), QIAGEN (Germany), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (United States), Danaher Corporation (United States) and Thermofisher Scientific (United States). Additionally, following companies can also be profiled that are part of our coverage like Abnova Corporation (Taiwan), BioGenex Laboratories (United States), Bio-Techne Corporation (United States) and Biocare Medical, and Bio SB (United States). Considering Market by Labels, the sub-segment i.e. Radioisotope will boost the RNA Probe market. Considering Market by End User, the sub-segment i.e. Clinical Research Institutes will boost the RNA Probe market.

Latest Market Insights:
In May 2021, New England Biolabs Inc., a leading supplier of life science reagents, had entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB.

In 2020, RNAscope ISH Detection Kit (Bio-Techne) received CE-IVD approval for BOND-III platform (Leica Biosystems) and In 2020, Creative Bioarray launched 2019 Novel Coronavirus Detection FISH probes to detect viral particles in infected cells & tissues.

What Can be Explored with the RNA Probe Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global RNA Probe Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in RNA Probe
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global RNA Probe market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in RNA Probe market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes RNA Probe Manufacturer, Raw Materials Supplier, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and End User.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Plus-Sense RNA Probes
  • Minus-Sense RNA Probes
  • Antisense RNA Probes
By Application
  • In Northern blotting
  • RNase protection assays
  • In situ hybridization
  • Southern blotting
By Labels
  • Radioisotope
  • - 32P
  • -125I
  • Chemical
  • - Biotin
  • Others

By End User
  • Clinical Research Institutes
  • Hospital & Diagnostic Laboratories
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Incidence of Cancer and Hereditary Diseases
      • 3.2.2. Need To Develop RNA-Based Biomarkers and Measure RNA Expression Has Increased
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
      • 3.3.2. Emerging Infections and Rapidly Evolving Pathogens
      • 3.3.3. Very Sensitive To Degradation by RNase
    • 3.4. Market Trends
      • 3.4.1. Focus on the development of personalized medicine and diagnostics tests
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global RNA Probe, by Type, Application, Labels, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global RNA Probe (Value)
      • 5.2.1. Global RNA Probe by: Type (Value)
        • 5.2.1.1. Plus-Sense RNA Probes
        • 5.2.1.2. Minus-Sense RNA Probes
        • 5.2.1.3. Antisense RNA Probes
      • 5.2.2. Global RNA Probe by: Application (Value)
        • 5.2.2.1. In Northern blotting
        • 5.2.2.2. RNase protection assays
        • 5.2.2.3. In situ hybridization
        • 5.2.2.4. Southern blotting
      • 5.2.3. Global RNA Probe by: Labels (Value)
        • 5.2.3.1. Radioisotope
        • 5.2.3.2. - 32P
        • 5.2.3.3. -125I
        • 5.2.3.4. Chemical
        • 5.2.3.5. - Biotin
        • 5.2.3.6. Others
      • 5.2.4. Global RNA Probe by: End User (Value)
        • 5.2.4.1. Clinical Research Institutes
        • 5.2.4.2. Hospital & Diagnostic Laboratories
        • 5.2.4.3. Academic Research Institutes
        • 5.2.4.4. Pharmaceutical & Biotechnology Companies
        • 5.2.4.5. Contract Research Organizations
        • 5.2.4.6. Others
      • 5.2.5. Global RNA Probe Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. RNA Probe: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sigma-Aldrich Co. LLC. (Argentina)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Signet Laboratories, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kamiya Biomedical Co (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sigma-Genosys (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Clontech Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Promega Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. New England Biolabs (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kaneka Eurogentec S.A. (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Advanced Cell Diagnostics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. QIAGEN (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Abbott Laboratories (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Agilent Technologies, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Danaher Corporation (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Thermofisher Scientific (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global RNA Probe Sale, by Type, Application, Labels, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global RNA Probe (Value)
      • 7.2.1. Global RNA Probe by: Type (Value)
        • 7.2.1.1. Plus-Sense RNA Probes
        • 7.2.1.2. Minus-Sense RNA Probes
        • 7.2.1.3. Antisense RNA Probes
      • 7.2.2. Global RNA Probe by: Application (Value)
        • 7.2.2.1. In Northern blotting
        • 7.2.2.2. RNase protection assays
        • 7.2.2.3. In situ hybridization
        • 7.2.2.4. Southern blotting
      • 7.2.3. Global RNA Probe by: Labels (Value)
        • 7.2.3.1. Radioisotope
        • 7.2.3.2. - 32P
        • 7.2.3.3. -125I
        • 7.2.3.4. Chemical
        • 7.2.3.5. - Biotin
        • 7.2.3.6. Others
      • 7.2.4. Global RNA Probe by: End User (Value)
        • 7.2.4.1. Clinical Research Institutes
        • 7.2.4.2. Hospital & Diagnostic Laboratories
        • 7.2.4.3. Academic Research Institutes
        • 7.2.4.4. Pharmaceutical & Biotechnology Companies
        • 7.2.4.5. Contract Research Organizations
        • 7.2.4.6. Others
      • 7.2.5. Global RNA Probe Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. RNA Probe: by Type(USD Million)
  • Table 2. RNA Probe Plus-Sense RNA Probes , by Region USD Million (2016-2021)
  • Table 3. RNA Probe Minus-Sense RNA Probes , by Region USD Million (2016-2021)
  • Table 4. RNA Probe Antisense RNA Probes , by Region USD Million (2016-2021)
  • Table 5. RNA Probe: by Application(USD Million)
  • Table 6. RNA Probe In Northern blotting , by Region USD Million (2016-2021)
  • Table 7. RNA Probe RNase protection assays , by Region USD Million (2016-2021)
  • Table 8. RNA Probe In situ hybridization , by Region USD Million (2016-2021)
  • Table 9. RNA Probe Southern blotting , by Region USD Million (2016-2021)
  • Table 10. RNA Probe: by Labels(USD Million)
  • Table 11. RNA Probe Radioisotope , by Region USD Million (2016-2021)
  • Table 12. RNA Probe - 32P , by Region USD Million (2016-2021)
  • Table 13. RNA Probe -125I , by Region USD Million (2016-2021)
  • Table 14. RNA Probe Chemical , by Region USD Million (2016-2021)
  • Table 15. RNA Probe - Biotin , by Region USD Million (2016-2021)
  • Table 16. RNA Probe Others , by Region USD Million (2016-2021)
  • Table 17. RNA Probe: by End User(USD Million)
  • Table 18. RNA Probe Clinical Research Institutes , by Region USD Million (2016-2021)
  • Table 19. RNA Probe Hospital & Diagnostic Laboratories , by Region USD Million (2016-2021)
  • Table 20. RNA Probe Academic Research Institutes , by Region USD Million (2016-2021)
  • Table 21. RNA Probe Pharmaceutical & Biotechnology Companies , by Region USD Million (2016-2021)
  • Table 22. RNA Probe Contract Research Organizations , by Region USD Million (2016-2021)
  • Table 23. RNA Probe Others , by Region USD Million (2016-2021)
  • Table 24. South America RNA Probe, by Country USD Million (2016-2021)
  • Table 25. South America RNA Probe, by Type USD Million (2016-2021)
  • Table 26. South America RNA Probe, by Application USD Million (2016-2021)
  • Table 27. South America RNA Probe, by Labels USD Million (2016-2021)
  • Table 28. South America RNA Probe, by End User USD Million (2016-2021)
  • Table 29. Brazil RNA Probe, by Type USD Million (2016-2021)
  • Table 30. Brazil RNA Probe, by Application USD Million (2016-2021)
  • Table 31. Brazil RNA Probe, by Labels USD Million (2016-2021)
  • Table 32. Brazil RNA Probe, by End User USD Million (2016-2021)
  • Table 33. Argentina RNA Probe, by Type USD Million (2016-2021)
  • Table 34. Argentina RNA Probe, by Application USD Million (2016-2021)
  • Table 35. Argentina RNA Probe, by Labels USD Million (2016-2021)
  • Table 36. Argentina RNA Probe, by End User USD Million (2016-2021)
  • Table 37. Rest of South America RNA Probe, by Type USD Million (2016-2021)
  • Table 38. Rest of South America RNA Probe, by Application USD Million (2016-2021)
  • Table 39. Rest of South America RNA Probe, by Labels USD Million (2016-2021)
  • Table 40. Rest of South America RNA Probe, by End User USD Million (2016-2021)
  • Table 41. Asia Pacific RNA Probe, by Country USD Million (2016-2021)
  • Table 42. Asia Pacific RNA Probe, by Type USD Million (2016-2021)
  • Table 43. Asia Pacific RNA Probe, by Application USD Million (2016-2021)
  • Table 44. Asia Pacific RNA Probe, by Labels USD Million (2016-2021)
  • Table 45. Asia Pacific RNA Probe, by End User USD Million (2016-2021)
  • Table 46. China RNA Probe, by Type USD Million (2016-2021)
  • Table 47. China RNA Probe, by Application USD Million (2016-2021)
  • Table 48. China RNA Probe, by Labels USD Million (2016-2021)
  • Table 49. China RNA Probe, by End User USD Million (2016-2021)
  • Table 50. Japan RNA Probe, by Type USD Million (2016-2021)
  • Table 51. Japan RNA Probe, by Application USD Million (2016-2021)
  • Table 52. Japan RNA Probe, by Labels USD Million (2016-2021)
  • Table 53. Japan RNA Probe, by End User USD Million (2016-2021)
  • Table 54. India RNA Probe, by Type USD Million (2016-2021)
  • Table 55. India RNA Probe, by Application USD Million (2016-2021)
  • Table 56. India RNA Probe, by Labels USD Million (2016-2021)
  • Table 57. India RNA Probe, by End User USD Million (2016-2021)
  • Table 58. South Korea RNA Probe, by Type USD Million (2016-2021)
  • Table 59. South Korea RNA Probe, by Application USD Million (2016-2021)
  • Table 60. South Korea RNA Probe, by Labels USD Million (2016-2021)
  • Table 61. South Korea RNA Probe, by End User USD Million (2016-2021)
  • Table 62. Taiwan RNA Probe, by Type USD Million (2016-2021)
  • Table 63. Taiwan RNA Probe, by Application USD Million (2016-2021)
  • Table 64. Taiwan RNA Probe, by Labels USD Million (2016-2021)
  • Table 65. Taiwan RNA Probe, by End User USD Million (2016-2021)
  • Table 66. Australia RNA Probe, by Type USD Million (2016-2021)
  • Table 67. Australia RNA Probe, by Application USD Million (2016-2021)
  • Table 68. Australia RNA Probe, by Labels USD Million (2016-2021)
  • Table 69. Australia RNA Probe, by End User USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific RNA Probe, by Type USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific RNA Probe, by Application USD Million (2016-2021)
  • Table 72. Rest of Asia-Pacific RNA Probe, by Labels USD Million (2016-2021)
  • Table 73. Rest of Asia-Pacific RNA Probe, by End User USD Million (2016-2021)
  • Table 74. Europe RNA Probe, by Country USD Million (2016-2021)
  • Table 75. Europe RNA Probe, by Type USD Million (2016-2021)
  • Table 76. Europe RNA Probe, by Application USD Million (2016-2021)
  • Table 77. Europe RNA Probe, by Labels USD Million (2016-2021)
  • Table 78. Europe RNA Probe, by End User USD Million (2016-2021)
  • Table 79. Germany RNA Probe, by Type USD Million (2016-2021)
  • Table 80. Germany RNA Probe, by Application USD Million (2016-2021)
  • Table 81. Germany RNA Probe, by Labels USD Million (2016-2021)
  • Table 82. Germany RNA Probe, by End User USD Million (2016-2021)
  • Table 83. France RNA Probe, by Type USD Million (2016-2021)
  • Table 84. France RNA Probe, by Application USD Million (2016-2021)
  • Table 85. France RNA Probe, by Labels USD Million (2016-2021)
  • Table 86. France RNA Probe, by End User USD Million (2016-2021)
  • Table 87. Italy RNA Probe, by Type USD Million (2016-2021)
  • Table 88. Italy RNA Probe, by Application USD Million (2016-2021)
  • Table 89. Italy RNA Probe, by Labels USD Million (2016-2021)
  • Table 90. Italy RNA Probe, by End User USD Million (2016-2021)
  • Table 91. United Kingdom RNA Probe, by Type USD Million (2016-2021)
  • Table 92. United Kingdom RNA Probe, by Application USD Million (2016-2021)
  • Table 93. United Kingdom RNA Probe, by Labels USD Million (2016-2021)
  • Table 94. United Kingdom RNA Probe, by End User USD Million (2016-2021)
  • Table 95. Netherlands RNA Probe, by Type USD Million (2016-2021)
  • Table 96. Netherlands RNA Probe, by Application USD Million (2016-2021)
  • Table 97. Netherlands RNA Probe, by Labels USD Million (2016-2021)
  • Table 98. Netherlands RNA Probe, by End User USD Million (2016-2021)
  • Table 99. Rest of Europe RNA Probe, by Type USD Million (2016-2021)
  • Table 100. Rest of Europe RNA Probe, by Application USD Million (2016-2021)
  • Table 101. Rest of Europe RNA Probe, by Labels USD Million (2016-2021)
  • Table 102. Rest of Europe RNA Probe, by End User USD Million (2016-2021)
  • Table 103. MEA RNA Probe, by Country USD Million (2016-2021)
  • Table 104. MEA RNA Probe, by Type USD Million (2016-2021)
  • Table 105. MEA RNA Probe, by Application USD Million (2016-2021)
  • Table 106. MEA RNA Probe, by Labels USD Million (2016-2021)
  • Table 107. MEA RNA Probe, by End User USD Million (2016-2021)
  • Table 108. Middle East RNA Probe, by Type USD Million (2016-2021)
  • Table 109. Middle East RNA Probe, by Application USD Million (2016-2021)
  • Table 110. Middle East RNA Probe, by Labels USD Million (2016-2021)
  • Table 111. Middle East RNA Probe, by End User USD Million (2016-2021)
  • Table 112. Africa RNA Probe, by Type USD Million (2016-2021)
  • Table 113. Africa RNA Probe, by Application USD Million (2016-2021)
  • Table 114. Africa RNA Probe, by Labels USD Million (2016-2021)
  • Table 115. Africa RNA Probe, by End User USD Million (2016-2021)
  • Table 116. North America RNA Probe, by Country USD Million (2016-2021)
  • Table 117. North America RNA Probe, by Type USD Million (2016-2021)
  • Table 118. North America RNA Probe, by Application USD Million (2016-2021)
  • Table 119. North America RNA Probe, by Labels USD Million (2016-2021)
  • Table 120. North America RNA Probe, by End User USD Million (2016-2021)
  • Table 121. United States RNA Probe, by Type USD Million (2016-2021)
  • Table 122. United States RNA Probe, by Application USD Million (2016-2021)
  • Table 123. United States RNA Probe, by Labels USD Million (2016-2021)
  • Table 124. United States RNA Probe, by End User USD Million (2016-2021)
  • Table 125. Canada RNA Probe, by Type USD Million (2016-2021)
  • Table 126. Canada RNA Probe, by Application USD Million (2016-2021)
  • Table 127. Canada RNA Probe, by Labels USD Million (2016-2021)
  • Table 128. Canada RNA Probe, by End User USD Million (2016-2021)
  • Table 129. Mexico RNA Probe, by Type USD Million (2016-2021)
  • Table 130. Mexico RNA Probe, by Application USD Million (2016-2021)
  • Table 131. Mexico RNA Probe, by Labels USD Million (2016-2021)
  • Table 132. Mexico RNA Probe, by End User USD Million (2016-2021)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. RNA Probe: by Type(USD Million)
  • Table 149. RNA Probe Plus-Sense RNA Probes , by Region USD Million (2022-2027)
  • Table 150. RNA Probe Minus-Sense RNA Probes , by Region USD Million (2022-2027)
  • Table 151. RNA Probe Antisense RNA Probes , by Region USD Million (2022-2027)
  • Table 152. RNA Probe: by Application(USD Million)
  • Table 153. RNA Probe In Northern blotting , by Region USD Million (2022-2027)
  • Table 154. RNA Probe RNase protection assays , by Region USD Million (2022-2027)
  • Table 155. RNA Probe In situ hybridization , by Region USD Million (2022-2027)
  • Table 156. RNA Probe Southern blotting , by Region USD Million (2022-2027)
  • Table 157. RNA Probe: by Labels(USD Million)
  • Table 158. RNA Probe Radioisotope , by Region USD Million (2022-2027)
  • Table 159. RNA Probe - 32P , by Region USD Million (2022-2027)
  • Table 160. RNA Probe -125I , by Region USD Million (2022-2027)
  • Table 161. RNA Probe Chemical , by Region USD Million (2022-2027)
  • Table 162. RNA Probe - Biotin , by Region USD Million (2022-2027)
  • Table 163. RNA Probe Others , by Region USD Million (2022-2027)
  • Table 164. RNA Probe: by End User(USD Million)
  • Table 165. RNA Probe Clinical Research Institutes , by Region USD Million (2022-2027)
  • Table 166. RNA Probe Hospital & Diagnostic Laboratories , by Region USD Million (2022-2027)
  • Table 167. RNA Probe Academic Research Institutes , by Region USD Million (2022-2027)
  • Table 168. RNA Probe Pharmaceutical & Biotechnology Companies , by Region USD Million (2022-2027)
  • Table 169. RNA Probe Contract Research Organizations , by Region USD Million (2022-2027)
  • Table 170. RNA Probe Others , by Region USD Million (2022-2027)
  • Table 171. South America RNA Probe, by Country USD Million (2022-2027)
  • Table 172. South America RNA Probe, by Type USD Million (2022-2027)
  • Table 173. South America RNA Probe, by Application USD Million (2022-2027)
  • Table 174. South America RNA Probe, by Labels USD Million (2022-2027)
  • Table 175. South America RNA Probe, by End User USD Million (2022-2027)
  • Table 176. Brazil RNA Probe, by Type USD Million (2022-2027)
  • Table 177. Brazil RNA Probe, by Application USD Million (2022-2027)
  • Table 178. Brazil RNA Probe, by Labels USD Million (2022-2027)
  • Table 179. Brazil RNA Probe, by End User USD Million (2022-2027)
  • Table 180. Argentina RNA Probe, by Type USD Million (2022-2027)
  • Table 181. Argentina RNA Probe, by Application USD Million (2022-2027)
  • Table 182. Argentina RNA Probe, by Labels USD Million (2022-2027)
  • Table 183. Argentina RNA Probe, by End User USD Million (2022-2027)
  • Table 184. Rest of South America RNA Probe, by Type USD Million (2022-2027)
  • Table 185. Rest of South America RNA Probe, by Application USD Million (2022-2027)
  • Table 186. Rest of South America RNA Probe, by Labels USD Million (2022-2027)
  • Table 187. Rest of South America RNA Probe, by End User USD Million (2022-2027)
  • Table 188. Asia Pacific RNA Probe, by Country USD Million (2022-2027)
  • Table 189. Asia Pacific RNA Probe, by Type USD Million (2022-2027)
  • Table 190. Asia Pacific RNA Probe, by Application USD Million (2022-2027)
  • Table 191. Asia Pacific RNA Probe, by Labels USD Million (2022-2027)
  • Table 192. Asia Pacific RNA Probe, by End User USD Million (2022-2027)
  • Table 193. China RNA Probe, by Type USD Million (2022-2027)
  • Table 194. China RNA Probe, by Application USD Million (2022-2027)
  • Table 195. China RNA Probe, by Labels USD Million (2022-2027)
  • Table 196. China RNA Probe, by End User USD Million (2022-2027)
  • Table 197. Japan RNA Probe, by Type USD Million (2022-2027)
  • Table 198. Japan RNA Probe, by Application USD Million (2022-2027)
  • Table 199. Japan RNA Probe, by Labels USD Million (2022-2027)
  • Table 200. Japan RNA Probe, by End User USD Million (2022-2027)
  • Table 201. India RNA Probe, by Type USD Million (2022-2027)
  • Table 202. India RNA Probe, by Application USD Million (2022-2027)
  • Table 203. India RNA Probe, by Labels USD Million (2022-2027)
  • Table 204. India RNA Probe, by End User USD Million (2022-2027)
  • Table 205. South Korea RNA Probe, by Type USD Million (2022-2027)
  • Table 206. South Korea RNA Probe, by Application USD Million (2022-2027)
  • Table 207. South Korea RNA Probe, by Labels USD Million (2022-2027)
  • Table 208. South Korea RNA Probe, by End User USD Million (2022-2027)
  • Table 209. Taiwan RNA Probe, by Type USD Million (2022-2027)
  • Table 210. Taiwan RNA Probe, by Application USD Million (2022-2027)
  • Table 211. Taiwan RNA Probe, by Labels USD Million (2022-2027)
  • Table 212. Taiwan RNA Probe, by End User USD Million (2022-2027)
  • Table 213. Australia RNA Probe, by Type USD Million (2022-2027)
  • Table 214. Australia RNA Probe, by Application USD Million (2022-2027)
  • Table 215. Australia RNA Probe, by Labels USD Million (2022-2027)
  • Table 216. Australia RNA Probe, by End User USD Million (2022-2027)
  • Table 217. Rest of Asia-Pacific RNA Probe, by Type USD Million (2022-2027)
  • Table 218. Rest of Asia-Pacific RNA Probe, by Application USD Million (2022-2027)
  • Table 219. Rest of Asia-Pacific RNA Probe, by Labels USD Million (2022-2027)
  • Table 220. Rest of Asia-Pacific RNA Probe, by End User USD Million (2022-2027)
  • Table 221. Europe RNA Probe, by Country USD Million (2022-2027)
  • Table 222. Europe RNA Probe, by Type USD Million (2022-2027)
  • Table 223. Europe RNA Probe, by Application USD Million (2022-2027)
  • Table 224. Europe RNA Probe, by Labels USD Million (2022-2027)
  • Table 225. Europe RNA Probe, by End User USD Million (2022-2027)
  • Table 226. Germany RNA Probe, by Type USD Million (2022-2027)
  • Table 227. Germany RNA Probe, by Application USD Million (2022-2027)
  • Table 228. Germany RNA Probe, by Labels USD Million (2022-2027)
  • Table 229. Germany RNA Probe, by End User USD Million (2022-2027)
  • Table 230. France RNA Probe, by Type USD Million (2022-2027)
  • Table 231. France RNA Probe, by Application USD Million (2022-2027)
  • Table 232. France RNA Probe, by Labels USD Million (2022-2027)
  • Table 233. France RNA Probe, by End User USD Million (2022-2027)
  • Table 234. Italy RNA Probe, by Type USD Million (2022-2027)
  • Table 235. Italy RNA Probe, by Application USD Million (2022-2027)
  • Table 236. Italy RNA Probe, by Labels USD Million (2022-2027)
  • Table 237. Italy RNA Probe, by End User USD Million (2022-2027)
  • Table 238. United Kingdom RNA Probe, by Type USD Million (2022-2027)
  • Table 239. United Kingdom RNA Probe, by Application USD Million (2022-2027)
  • Table 240. United Kingdom RNA Probe, by Labels USD Million (2022-2027)
  • Table 241. United Kingdom RNA Probe, by End User USD Million (2022-2027)
  • Table 242. Netherlands RNA Probe, by Type USD Million (2022-2027)
  • Table 243. Netherlands RNA Probe, by Application USD Million (2022-2027)
  • Table 244. Netherlands RNA Probe, by Labels USD Million (2022-2027)
  • Table 245. Netherlands RNA Probe, by End User USD Million (2022-2027)
  • Table 246. Rest of Europe RNA Probe, by Type USD Million (2022-2027)
  • Table 247. Rest of Europe RNA Probe, by Application USD Million (2022-2027)
  • Table 248. Rest of Europe RNA Probe, by Labels USD Million (2022-2027)
  • Table 249. Rest of Europe RNA Probe, by End User USD Million (2022-2027)
  • Table 250. MEA RNA Probe, by Country USD Million (2022-2027)
  • Table 251. MEA RNA Probe, by Type USD Million (2022-2027)
  • Table 252. MEA RNA Probe, by Application USD Million (2022-2027)
  • Table 253. MEA RNA Probe, by Labels USD Million (2022-2027)
  • Table 254. MEA RNA Probe, by End User USD Million (2022-2027)
  • Table 255. Middle East RNA Probe, by Type USD Million (2022-2027)
  • Table 256. Middle East RNA Probe, by Application USD Million (2022-2027)
  • Table 257. Middle East RNA Probe, by Labels USD Million (2022-2027)
  • Table 258. Middle East RNA Probe, by End User USD Million (2022-2027)
  • Table 259. Africa RNA Probe, by Type USD Million (2022-2027)
  • Table 260. Africa RNA Probe, by Application USD Million (2022-2027)
  • Table 261. Africa RNA Probe, by Labels USD Million (2022-2027)
  • Table 262. Africa RNA Probe, by End User USD Million (2022-2027)
  • Table 263. North America RNA Probe, by Country USD Million (2022-2027)
  • Table 264. North America RNA Probe, by Type USD Million (2022-2027)
  • Table 265. North America RNA Probe, by Application USD Million (2022-2027)
  • Table 266. North America RNA Probe, by Labels USD Million (2022-2027)
  • Table 267. North America RNA Probe, by End User USD Million (2022-2027)
  • Table 268. United States RNA Probe, by Type USD Million (2022-2027)
  • Table 269. United States RNA Probe, by Application USD Million (2022-2027)
  • Table 270. United States RNA Probe, by Labels USD Million (2022-2027)
  • Table 271. United States RNA Probe, by End User USD Million (2022-2027)
  • Table 272. Canada RNA Probe, by Type USD Million (2022-2027)
  • Table 273. Canada RNA Probe, by Application USD Million (2022-2027)
  • Table 274. Canada RNA Probe, by Labels USD Million (2022-2027)
  • Table 275. Canada RNA Probe, by End User USD Million (2022-2027)
  • Table 276. Mexico RNA Probe, by Type USD Million (2022-2027)
  • Table 277. Mexico RNA Probe, by Application USD Million (2022-2027)
  • Table 278. Mexico RNA Probe, by Labels USD Million (2022-2027)
  • Table 279. Mexico RNA Probe, by End User USD Million (2022-2027)
  • Table 280. Research Programs/Design for This Report
  • Table 281. Key Data Information from Secondary Sources
  • Table 282. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global RNA Probe: by Type USD Million (2016-2021)
  • Figure 5. Global RNA Probe: by Application USD Million (2016-2021)
  • Figure 6. Global RNA Probe: by Labels USD Million (2016-2021)
  • Figure 7. Global RNA Probe: by End User USD Million (2016-2021)
  • Figure 8. South America RNA Probe Share (%), by Country
  • Figure 9. Asia Pacific RNA Probe Share (%), by Country
  • Figure 10. Europe RNA Probe Share (%), by Country
  • Figure 11. MEA RNA Probe Share (%), by Country
  • Figure 12. North America RNA Probe Share (%), by Country
  • Figure 13. Global RNA Probe share by Players 2021 (%)
  • Figure 14. Global RNA Probe share by Players (Top 3) 2021(%)
  • Figure 15. Global RNA Probe share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sigma-Aldrich Co. LLC. (Argentina) Revenue, Net Income and Gross profit
  • Figure 18. Sigma-Aldrich Co. LLC. (Argentina) Revenue: by Geography 2021
  • Figure 19. Signet Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Signet Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Kamiya Biomedical Co (United States) Revenue, Net Income and Gross profit
  • Figure 22. Kamiya Biomedical Co (United States) Revenue: by Geography 2021
  • Figure 23. Sigma-Genosys (United States) Revenue, Net Income and Gross profit
  • Figure 24. Sigma-Genosys (United States) Revenue: by Geography 2021
  • Figure 25. Clontech Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Clontech Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Promega Corporation (United States) Revenue: by Geography 2021
  • Figure 29. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 30. New England Biolabs (United States) Revenue: by Geography 2021
  • Figure 31. Kaneka Eurogentec S.A. (Belgium) Revenue, Net Income and Gross profit
  • Figure 32. Kaneka Eurogentec S.A. (Belgium) Revenue: by Geography 2021
  • Figure 33. Advanced Cell Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Advanced Cell Diagnostics, Inc. (United States) Revenue: by Geography 2021
  • Figure 35. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 36. QIAGEN (Germany) Revenue: by Geography 2021
  • Figure 37. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 38. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 39. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2021
  • Figure 41. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Agilent Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 43. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Danaher Corporation (United States) Revenue: by Geography 2021
  • Figure 45. Thermofisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 46. Thermofisher Scientific (United States) Revenue: by Geography 2021
  • Figure 47. Global RNA Probe: by Type USD Million (2022-2027)
  • Figure 48. Global RNA Probe: by Application USD Million (2022-2027)
  • Figure 49. Global RNA Probe: by Labels USD Million (2022-2027)
  • Figure 50. Global RNA Probe: by End User USD Million (2022-2027)
  • Figure 51. South America RNA Probe Share (%), by Country
  • Figure 52. Asia Pacific RNA Probe Share (%), by Country
  • Figure 53. Europe RNA Probe Share (%), by Country
  • Figure 54. MEA RNA Probe Share (%), by Country
  • Figure 55. North America RNA Probe Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sigma-Aldrich Co. LLC. (Argentina)
  • Signet Laboratories, Inc. (United States)
  • Kamiya Biomedical Co (United States)
  • Sigma-Genosys (United States)
  • Clontech Laboratories, Inc. (United States)
  • Promega Corporation (United States)
  • New England Biolabs (United States)
  • Kaneka Eurogentec S.A. (Belgium)
  • Advanced Cell Diagnostics, Inc. (United States)
  • QIAGEN (Germany)
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Agilent Technologies, Inc. (United States)
  • Danaher Corporation (United States)
  • Thermofisher Scientific (United States)
Additional players considered in the study are as follows:
Abnova Corporation (Taiwan) , BioGenex Laboratories (United States) , Bio-Techne Corporation (United States) , Biocare Medical, and Bio SB (United States)
Select User Access Type

Key Highlights of Report


Aug 2022 207 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global RNA Probe Market Quantitative research analysis
Global RNA Probe Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global RNA Probe market are Sigma-Aldrich Co. LLC. (Argentina), Signet Laboratories, Inc. (United States), Kamiya Biomedical Co (United States), Sigma-Genosys (United States), Clontech Laboratories, Inc. (United States), Promega Corporation (United States), New England Biolabs (United States), Kaneka Eurogentec S.A. (Belgium), Advanced Cell Diagnostics, Inc. (United States), QIAGEN (Germany), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (United States), Danaher Corporation (United States) and Thermofisher Scientific (United States), to name a few.
"Focus on the development of personalized medicine and diagnostics tests" is seen as one of major influencing trends for RNA Probe Market during projected period 2021-2027.
Plus-Sense RNA Probes segment in Global market to hold robust market share owing to "Growing Incidence of Cancer and Hereditary Diseases ".

Know More About Global RNA Probe Market Report?

Have a Query? Click Here

Other Related Reports

Vehicle Mobile CT Comprehensive Study by Application (Hospital, Clinic), Vehicle Type (Car, Truck, Others) Players and Region - Global Market Outlook to 2027
$ 3800
Pets Vitamins and Supplement Comprehensive Study by Type (Tablets, Powder, Chewable, Other), Application (Multivitamins, Prebiotics & Probiotics, Calming, Other), End Users (Commercial, Residential, ...
$ 4000
Pharmacy Safes Comprehensive Study by Type (Fire Rated, High Securities Safes, Burglary Safes, Others), Application (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2027
$ 3800
Healthcare Finance Solution Comprehensive Study by Type (Equipment And Technology Finance, Working Capital Finance, Project Finance Solutions, Corporate Lending), Application (Hospitals, Laboratories...
$ 3600
Thyroid Stimulating Hormone Detection Reagent Comprehensive Study by Application (Hospitals, Laboratories, Diagnostic Centre’s, Clinic), TSH tests (T3, T4, T3RU, TSH) Players and Region - Global Mark...
$ 3800
DNA Sequencing In Drugs Discovery Comprehensive Study by Type (Shotgun (Sanger) DNA Sequencing, High Throughput), Method (Maxam And Gilbert Method, Chain Termination Method, Semiautomated Method, Aut...
$ 3800